Brief: ChromaDex Corporation Q3 EPS USD -0.01
08/11/2023 21:52
Nov 8 (Reuters) - ChromaDex Corporation Q3 EPS USD -0.01. * Q3 operating expenses USD 13.116 million * Q3 net income USD -959 thousand * Q3 operating income USD -1.147 million * Q3 sales USD 19.495 million vs. IBES estimate USD 20.2 million * Q3 gross profit USD 11.969 million
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce